Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi

28 Jul 2021

Abstract excerpt

Clonal multidrug resistance recently emerged in Rhodococcus equi , complicating the therapeutic management of this difficult-to-treat animal- and human-pathogenic actinomycete. The currently spreading multidrug-resistant (MDR) “2287” clone arose in equine farms upon acquisition, and coselection by mass macrolide-rifampin therapy, of the pRErm46 plasmid carrying the erm (46) macrolide-lincosamide-streptogramin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infections and bacterial resistance
Share to Infectious Disease Case Reports and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34319806
DOI: 10.1128/jcm.01149-21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equiPMID 34319806Read ↗

Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equiSemantic proximity Read ↗

Horizontal Spread of Rhodococcus equi Macrolide Resistance Plasmid pRErm46 across Environmental ActinobacteriaSemantic proximity Read ↗

Novel transferableerm(46) determinant responsible for emerging macrolide resistance inRhodococcus equiSemantic proximity Read ↗

The novel and transferable erm (51) gene confers macrolides, lincosamides and streptogramins B ( MLS B ) resistance to clonal Rhodococcus equi in the environmentSemantic proximity Read ↗

Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equiSemantic proximity Read ↗

Genomic diversity of multidrug-resistant Rhodococcus equi: novel sequence types, pangenome architecture, and phylogenomic evolution.Semantic proximity Read ↗

Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equiSemantic proximity Read ↗

International Spread of Multidrug-Resistant Rhodococcus equiSemantic proximity Read ↗

Fitness cost conferred by the novel erm(51) and rpoB mutation on environmental multidrug resistant-Rhodococcus equi.Semantic proximity Read ↗

Characterization of genotypic and phenotypic resistance profiles in clinical isolates in an equine production in the state of MexicoSemantic proximity Read ↗

Spread of Multidrug-Resistant Rhodococcus equi, United StatesSemantic proximity Read ↗

MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal originSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.